Phenotyping of lymphocytes expressing regulatory and effector markers in infiltrating ductal carcinoma of the breast
- 1 February 2006
- journal article
- case report
- Published by Elsevier BV in Immunology Letters
- Vol. 102 (2), 229-236
- https://doi.org/10.1016/j.imlet.2005.09.006
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humansHuman Immunology, 2005
- Suppressive properties of human CD4+CD25+ regulatory T cells are dependent on CTLA‐4 expressionEuropean Journal of Immunology, 2004
- Immunoregulatory T cells in tumor immunityCurrent Opinion in Immunology, 2004
- Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28− T cells and inhibit both T-Cell proliferation and CTL functionHuman Immunology, 2004
- The immunophenotype and activation status of the lymphocytic infiltrate in human breast cancers, the role of the major histocompatibility complex in cell-mediated immune mechanisms, and their association with prognostic indicatorsSurgery, 2003
- Functional assay for human CD4+CD25+ Treg cells reveals an age‐dependent loss of suppressive activityJournal of Neuroscience Research, 2003
- Control of Regulatory T Cell Development by the Transcription Factor Foxp3Science, 2003
- Proliferative arrest and cell cycle regulation in CD8+CD28− versus CD8+CD28+ T cellsHuman Immunology, 2002
- Role of oestrogen receptors α and β in immune organ development and in oestrogen‐mediated effects on thymusImmunology, 2001
- Interactions Between the Immune System and Breast CancerActa Oncologica, 1995